Last reviewed · How we verify
Phase Ia dose-escalation part of FB849 Monotherapy
Phase Ia dose-escalation part of FB849 Monotherapy is a Small molecule drug developed by 1ST Biotherapeutics, Inc.. It is currently in Phase 1 development. Also known as: FB849.
At a glance
| Generic name | Phase Ia dose-escalation part of FB849 Monotherapy |
|---|---|
| Also known as | FB849 |
| Sponsor | 1ST Biotherapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phase Ia dose-escalation part of FB849 Monotherapy CI brief — competitive landscape report
- Phase Ia dose-escalation part of FB849 Monotherapy updates RSS · CI watch RSS
- 1ST Biotherapeutics, Inc. portfolio CI
Frequently asked questions about Phase Ia dose-escalation part of FB849 Monotherapy
What is Phase Ia dose-escalation part of FB849 Monotherapy?
Phase Ia dose-escalation part of FB849 Monotherapy is a Small molecule drug developed by 1ST Biotherapeutics, Inc..
Who makes Phase Ia dose-escalation part of FB849 Monotherapy?
Phase Ia dose-escalation part of FB849 Monotherapy is developed by 1ST Biotherapeutics, Inc. (see full 1ST Biotherapeutics, Inc. pipeline at /company/1st-biotherapeutics-inc).
Is Phase Ia dose-escalation part of FB849 Monotherapy also known as anything else?
Phase Ia dose-escalation part of FB849 Monotherapy is also known as FB849.
What development phase is Phase Ia dose-escalation part of FB849 Monotherapy in?
Phase Ia dose-escalation part of FB849 Monotherapy is in Phase 1.
Related
- Manufacturer: 1ST Biotherapeutics, Inc. — full pipeline
- Also known as: FB849
- Compare: Phase Ia dose-escalation part of FB849 Monotherapy vs similar drugs
- Pricing: Phase Ia dose-escalation part of FB849 Monotherapy cost, discount & access